Compare Definium Therapeutics Inc. Common Shares (DFTX) vs MACOM Technology (MTSI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs MACOM Technology — how do they compare? Definium Therapeutics Inc. Common Shares trades at $34.01 (market cap $4.71B), while MACOM Technology trades at $326 (market cap $25.65B). The key difference: MACOM Technology is far larger — about 5.4× Definium Therapeutics Inc. Common Shares's market cap, and Definium Therapeutics Inc. Common Shares is more actively traded (1,966,636 versus 1,518,856). Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and MACOM Technology for 6 Days on average.
| DFTX | MTSI | |
|---|---|---|
Market Cap | $4.71B | $25.65B |
Volume | 1,966,636 | 1,518,856 |
Sector | Health | Technology |
52-Week High | $48.45 | $409.68 |
52-Week Low | $10.68 | $122.18 |
Typical Hold Time | 0 Days | 6 Days |
Enterprise Value | $3.67B | $25.37B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About MACOM Technology
MACOM develops analog, radio frequency, microwave, and optical semiconductors. Its components are used in telecommunications, data centers, industrial systems, aerospace, and defense applications.
Read more on MTSI →
